estimated revenue glp-1 drugs Market Size, Scope, Forecast Report 2026 to 2035 Consumers' Expectations about GLP-1 Drugs
Description
95% CI, 0.62-0.86
The Forest plot shows hazard ratios (HR) and 95% confidence intervals (CI) of all study endpoints in patients who initiated BI versus those who initiated a human- or exendin-based GLP-1RA
J Clin Endocrinol Metab 37(5):826828 Elahi D, Andersen DK, Brown JC et al (1979) Pancreatic alpha-and beta-cell responses to GIP infusion in normal man
2 The American Diabetes Association 2016 guideline details a number of second-line options for use following MET and does not give preference to one drug class over the other
The Food and Drug Administration (FDA) has issued specific guidance for sponsors of new drugs to encourage evaluation of potential DDI with COCs [42]
